Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 1942-1952

  Mahar, Jackie E ^a,b   Donker, Nicole C ^a,b   Bok, Karin ^c   Talbo, Gert H ^b,d   Green, Kim Y ^c   Kirkwood, Carl D ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CAPSID PROTEINS; CHROMATOGRAPHY, LIQUID; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GASTROENTERITIS; HUMANS; IMMUNITY, HERD; IMMUNOPRECIPITATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NOROVIRUS; RABBITS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TANDEM MASS SPECTROMETRY;

EID: 84893486323     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02992-13     Document Type: Article

References (60)

1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15. http://dx.doi.org/10.3201/eid1701.091101p1.
2. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 14:1224-1231. http://dx.doi.org/10.3201/eid1408.071114.
3. Xi JN, Graham DY, Wang KN, Estes MK. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583. http://dx.doi.org/10.1126/science.2177224.
4. Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Matson DO, Nakata S, Neill JD, Studdert MJ, Thiel HJ. 2000. Taxonomy of the caliciviruses. J. Infect. Dis. 181(Suppl 2):S322-S330. http://dx.doi.org/10.1086/315591.
5. Katayama K. 2002. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology 299:225-239. http://dx.doi.org/10.1006/viro.2002.1568.
6. Jiang X, Wang M, Wang K, Estes MK. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61. http://dx.doi.org/10.1006/viro.1993.1345.
7. Bertolotti-Ciarlet A, Crawford SE, Hutson AM, Estes MK. 2003. The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol. 77:11603-11615. http://dx.doi.org/10.1128/JVI.77.21.11603-11615.2003.
8. Mesquita JR, Barclay L, Nascimento MS, Vinje J. 2010. Novel norovirus in dogs with diarrhea. Emerg. Infect. Dis. 16:980-982. http://dx.doi.org/10.3201/eid1606.091861.
9. Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch. Virol. 158:2059-2068. http://dx.doi.org/10.1007/s00705-013-1708-5.
10. Boon D, Mahar JE, Abente EJ, Kirkwood CD, Purcell RH, Kapikian AZ, Green KY, Bok K. 2011. Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J. Virol. 85:8656-8666. http://dx.doi.org/10.1128/JVI.00472-11.
11. Wright PJ, Gunesekere IC, Doultree JC, Marshall JA. 1998. Small roundstructured (Norwalk-like) viruses and classical human caliciviruses in southeastern Australia, 1980-1996. J. Med. Virol. 55:312-320. http://dx.doi.org/10.1002/(SICI)1096-9071(199808)55:4<312::AID-JMV10>3.0.CO;2-G.
12. Guo L, Song J, Xu X, Ren L, Li J, Zhou H, Wang M, Qu J, Wang J, Hung T. 2009. Genetic analysis of norovirus in children affected with acute gastroenteritis in Beijing, 2004-2007. J. Clin. Virol. 44:94-98. http://dx.doi.org/10.1016/j.jcv.2008.10.002.
13. Sdiri-Loulizi K, Ambert-Balay K, Gharbi-Khelifi H, Sakly N, Hassine M, Chouchane S, Guediche MN, Pothier P, Aouni M. 2009. Molecular epidemiology of norovirus gastroenteritis investigated using samples collected from children in Tunisia during a four-year period: detection of the norovirus variant GGII.4 Hunter as early as January 2003. J. Clin. Microbiol. 47:421-429. http://dx.doi.org/10.1128/JCM.01852-08.
14. Parker SP, Cubitt WD, Jiang X. 1995. Enzyme immunoassay using baculovirus-expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK. J. Med. Virol. 46:194-200. http://dx.doi.org/10.1002/jmv.1890460305.
15. Smit TK, Steele AD, Peenze I, Jiang X, Estes MK. 1997. Study of Norwalk virus and Mexico virus infections at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa. J. Clin. Microbiol. 35:2381-2385.
16. Levett PN, Gu M, Luan B, Fearon M, Stubberfield J, Jamieson F, Petric M. 1996. Longitudinal study of molecular epidemiology of small roundstructured viruses in a pediatric population. J. Clin. Microbiol. 34:1497-1501.
17. Chhabra P, Dhongade RK, Kalrao VR, Bavdekar AR, Chitambar SD. 2009. Epidemiological, clinical, and molecular features of norovirus infections in western India. J. Med. Virol. 81:922-932. http://dx.doi.org/10.1002/jmv.21458.
18. Phan TG, Kaneshi K, Ueda Y, Nakaya S, Nishimura S, Yamamoto A, Sugita K, Takanashi S, Okitsu S, Ushijima H. 2007. Genetic heterogeneity, evolution, and recombination in noroviruses. J. Med. Virol. 79:1388-1400. http://dx.doi.org/10.1002/jmv.20924.
19. Phan TG, Kuroiwa T, Kaneshi K, Ueda Y, Nakaya S, Nishimura S, Yamamoto A, Sugita K, Nishimura T, Yagyu F, Okitsu S, Muller WE, Maneekarn N, Ushijima H. 2006. Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in Japan. J. Med. Virol. 78:971-978. http://dx.doi.org/10.1002/jmv.20649.
20. Mahar JE, Kirkwood CD. 2011. Characterization of norovirus strains in Australian children from 2006 to 2008: prevalence of recombinant strains. J. Med. Virol. 83:2213-2219. http://dx.doi.org/10.1002/jmv.22215.
21. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science286:287-290. http://dx.doi.org/10.1126/science.286.5438.287.
22. Debbink K, Donaldson EF, Lindesmith LC, Baric RS. 2012. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J. Virol. 86:1214-1226. http://dx.doi.org/10.1128/JVI.06189-11.
23. Lindesmith LC, Debbink K, Swanstrom J, Vinje J, Costantini V, Baric RS, Donaldson EF. 2012. Monoclonal antibody-based antigenic mapping of norovirus GII. 4-2002. J. Virol. 86:873-883. http://dx.doi.org/10.1128/JVI.06200-11.
24. Hansman GS, Biertumpfel C, Georgiev I, Mclellan JS, Chen L, Zhou T, Katayama K, Kwong PD. 2011. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J. Virol. 85:6687-6701. http://dx.doi.org/10.1128/JVI.00246-11.
25. Cao S, Lou Z, Tan M, Chen Y, Liu Y, Zhang Z, Zhang XC, Jiang X, Li X, Rao Z. 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 81:5949-5957. http://dx.doi.org/10.1128/JVI.00219-07.
26. Tan M, Xia M, Cao S, Huang P, Farkas T, Meller J, Hegde RS, Li X, Rao Z, Jiang X. 2008. Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 379:324-334. http://dx.doi.org/10.1016/j.virol.2008.06.041.
27. Hale AD, Tanaka TN, Kitamoto N, Ciarlet M, Jiang X, Takeda N, Brown DW, Estes MK. 2000. Identification of an epitope common to genogroup 1 "Norwalk-like viruses." J. Clin. Microbiol. 38:1656-1660.
28. Parker TD, Kitamoto N, Tanaka T, Hutson AM, Estes MK. 2005. Identification of genogroup I and genogroup II broadly reactive epitopes on the norovirus capsid. J. Virol. 79:7402-7409. http://dx.doi.org/10.1128/JVI.79.12.7402-7409.2005.
29. Parra GI, Abente EJ, Sandoval-Jaime C, Sosnovtsev SV, Bok K, Green KY. 2012. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens. J. Virol. 86:7414-7426. http://dx.doi.org/10.1128/JVI.06729-11.
30. Allen DJ, Noad R, Samuel D, Gray JJ, Roy P, Iturriza-Gomara M. 2009. Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol. J. 6:150. http://dx.doi.org/10.1186/1743-422X-6-150.
31. Yoda T, Suzuki Y, Terano Y, Yamazaki K, Sakon N, Kuzuguchi T, Oda H, Tsukamoto T. 2003. Precise characterization of norovirus (Norwalklike virus)-specific monoclonal antibodies with broad reactivity. J. Clin. Microbiol. 41:2367-2371. http://dx.doi.org/10.1128/JCM.41.6.2367-2371.2003.
32. Batten CA, Clarke IN, Kempster SL, Oliver SL, Bridger JC, Lambden PR. 2006. Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins. Virology 356:179-187. http://dx.doi.org/10.1016/j.virol.2006.07.034.
33. Oliver SL, Batten CA, Deng Y, Elschner M, Otto P, Charpilienne A, Clarke IN, Bridger JC, Lambden PR. 2006. Genotype 1 and genotype 2 bovine noroviruses are antigenically distinct but share a cross-reactive epitope with human noroviruses. J. Clin. Microbiol. 44:992-998. http://dx.doi.org/10.1128/JCM.44.3.992-998.2006.
34. Lochridge VP. 2005. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J. Gen. Virol. 86:2799-2806. http://dx.doi.org/10.1099/vir.0.81134-0.
35. Hansman GS, Taylor DW, Mclellan JS, Smith TJ, Georgiev I, Tame JRH, Park SY, Yamazaki M, Gondaira F, Miki M, Katayama K, Murata K, Kwong PD. 2012. Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J. Virol. 86:3635-3646. http://dx.doi.org/10.1128/JVI.06868-11.
36. Li X, Zhou R, Wang Y, Sheng H, Tian X, Li H, Qiu H. 2009. Identification and characterization of a native epitope common to norovirus strains GII/4, GII/7 and GII/8. Virus Res. 140:188-193. http://dx.doi.org/10.1016/j.virusres.2008.12.004.
37. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. 2012. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog. 8:e1002705. http://dx.doi.org/10.1371/journal.ppat.1002705.
38. Lindesmith LC, Donaldson E, Leon J, Moe CL, Frelinger JA, Johnston RE, Weber DJ, Baric RS. 2010. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J. Virol. 84:1800-1815. http://dx.doi.org/10.1128/JVI.02179-09.
39. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, Mendelman PM. 2011. Norovirus vaccine against experimental human Norwalk Virus illness. N. Engl. J. Med. 365:2178-2187. http://dx.doi.org/10.1056/NEJMoa1101245.
40. Ramirez K, Wahid R, Richardson C, Bargatze RF, El-Kamary SS, Sztein MB, Pasetti MF. 2012. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin. Immunol. 144:98-108. http://dx.doi.org/10.1016/j.clim.2012.05.006.
41. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, selfassembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
42. Tan M, Jiang X. 2012. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine (Lond.) 7:889-897. http://dx.doi.org/10.2217/nnm.12.62.
43. Parra GI, Bok K, Taylor R, Haynes J, Sosnovtsev SV, Richardson C, Green KY. 2012. Immunogenicity and specificity of norovirus consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 30:3580-3586. http://dx.doi.org/10.1016/j.vaccine.2012.03.050.
44. Okame M, Shiota T, Hansman G, Takagi M, Yagyu F, Takanashi S, Phan TG, Shimizu Y, Kohno H, Okitsu S, Ushijima H. 2007. Antinorovirus polyclonal antibody and its potential for development of an antigen-ELISA. J. Med. Virol. 79:1180-1186. http://dx.doi.org/10.1002/jmv.20906.
45. Rockx B, Baric RS, De Grijs I, Duizer E, Koopmans MP. 2005. Characterization of the homo-and heterotypic immune responses after natural norovirus infection. J. Med. Virol. 77:439-446. http://dx.doi.org/10.1002/jmv.20473.
46. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, Kapikian AZ, Green KY. 2009. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J. Virol. 83:11890-11901. http://dx.doi.org/10.1128/JVI.00864-09.
47. Mahar JE, Bok K, Green KY, Kirkwood CD. 2013. The importance of intergenic recombination in norovirus GII.3 evolution. J. Virol. 87:3687-3698. http://dx.doi.org/10.1128/JVI.03056-12.
48. Kroneman A, Vennema H, Deforche K, Avoort HVD, Peñaranda S, Oberste MS, Vinjé J, Koopmans M. 2011. An automated genotyping tool for enteroviruses and noroviruses. J. Clin. Virol. 51:121-125. http://dx.doi.org/10.1016/j.jcv.2011.03.006.
49. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
50. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5:725-738. http://dx.doi.org/10.1038/nprot.2010.5.
51. Schrödinger LLC. 2010. The PyMOL molecular graphics system, version 1.3. Schrödinger, LLC, New York, NY.
52. Hansman GS, Natori K, Shirato-Horikoshi H, Ogawa S, Oka T, Katayama K, Tanaka T, Miyoshi T, Sakae K, Kobayashi S, Shinohara M, Uchida K, Sakurai N, Shinozaki K, Okada M, Seto Y, Kamata K, Nagata N, Tanaka K, Miyamura T, Takeda N. 2006. Genetic and antigenic diversity among noroviruses. J. Gen. Virol. 87:909-919. http://dx.doi.org/10.1099/vir.0.81532-0.
53. Belliot G, Noel JS, Li JF, Seto Y, Humphrey CD, Ando T, Glass RI, Monroe SS. 2001. Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses." J. Clin. Microbiol. 39:4288-4295. http://dx.doi.org/10.1128/JCM.39.12.4288-4295.2001.
54. Donker NC, Foley M, Tamvakis DC, Bishop R, Kirkwood CD. 2011. Identification of an antibody-binding epitope on the rotavirus A nonstructural protein NSP2 using phage display analysis. J. Gen. Virol. 92: 2374-2382. http://dx.doi.org/10.1099/vir.0.032599-0.
55. Wright A, Yan H, Lamm ME, Huang YT. 2006. Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells. Virology 356:165-170. http://dx.doi.org/10.1016/j.virol.2006.08.006.
56. Vongpunsawad S, Prasad BV, Estes MK. 2013. Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain. J. Virol. 87: 4818-4825. http://dx.doi.org/10.1128/JVI.03508-12.
57. Parra GI, Azure J, Fischer R, Bok K, Sandoval-Jaime C, Sosnovtsev SV, Sander P, Green KY. 2013. Identification of a broadly cross-reactive epitope in the inner shell of the norovirus capsid. PLoS One 8:e67592. http://dx.doi.org/10.1371/journal.pone.0067592.
58. Yoda T, Terano Y, Suzuki Y, Yamazaki K, Oishi I, Utagawa E, Shimada A, Matsuura S, Nakajima M, Shibata T. 2000. Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli. Microbiol. Immunol. 44:905-914. http://dx.doi.org/10.1111/j.1348-0421.2000.tb02582.x.
59. Novotny J. 1991. Protein antigenicity: a thermodynamic approach. Mol. Immunol. 28:201-207. http://dx.doi.org/10.1016/0161-5890(91)90062-O.
60. Tan M, Xia M, Chen Y, Bu W, Hegde RS, Meller J, Li X, Jiang X. 2009. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 4:e5058. http://dx.doi.org/10.1371/journal.pone.0005058.